News for 'General Data Protection Regulation'

'Protecting Mother Earth should become a habit'

'Protecting Mother Earth should become a habit'

Rediff.com24 Oct 2021

'When we talk of disaster, it is a combination of hazard and vulnerability.' 'If we reduce vulnerability, it will remain a hazard.'

Adani-Hindenberg row: Sebi gets time till Aug 14 to complete probe

Adani-Hindenberg row: Sebi gets time till Aug 14 to complete probe

Rediff.com17 May 2023

The Supreme Court on Wednesday granted the Securities and Exchange Board of India time till August 14 to complete its probe into the allegations of stock price manipulation by the Adani group. A bench headed by Chief Justice D Y Chandrachud directed the SEBI to file an updated status report of the investigation.

Blocking apps: Acid test for India's cyber laws

Blocking apps: Acid test for India's cyber laws

Rediff.com14 Jul 2020

The advent of artificial intelligence, blockchain technology and cryptocurrencies, and the increasing use of Internet of Things devices throw techno-legal challenges regarding privacy and security. Experts say, any expansion of power to the government to block web-services is detrimental to the interests of users, innovation, and India's larger technology ecosystem. The move to block the mobile apps is likely to have a lasting impact on the data security and privacy framework.

'Cybercrime has surpassed drug trafficking'

'Cybercrime has surpassed drug trafficking'

Rediff.com22 Dec 2022

Financial institutions are 300 times more vulnerable to cyberattacks than any other industry.

Monkeypox declared a public health emergency in New York City

Monkeypox declared a public health emergency in New York City

Rediff.com31 Jul 2022

New York City mayor Eric Adams and New York City department of health and mental hygiene commissioner Ashwin Vasan on Saturday declared a public health emergency due to the monkeypox outbreak.

IAEA loses contact with monitoring system of Chernobyl nuclear plant

IAEA loses contact with monitoring system of Chernobyl nuclear plant

Rediff.com9 Mar 2022

The Chernobyl nuclear power plant, which was taken over by Russian forces last month, has stopped transmitting data to the International Atomic Energy Agency (IAEA), the United Nations atomic watchdog has said, expressing deep concern for the staff working under Russian troops at the nuclear site in northern Ukraine.

Who will win the Super App race in India?

Who will win the Super App race in India?

Rediff.com10 Oct 2021

Unlike the race to buy airwaves by telecom companies, airports by infrastructure companies and city gas networks by energy companies, the race to develop super apps by consumer-facing companies in India has not brushed up against any regulatory issues. Officials at the ministry of electronics and information technology and at other regulators are happy they do not have to meddle in who among the Tata group, Reliance Industries Ltd, Flipkart or Paytm will manage to build an app that sweeps in customers. Unlike separate apps a customer uses on her mobile to order groceries, buy food or airline tickets or just make payments, a super app can perform all these functions.

WHO declares monkeypox global health emergency

WHO declares monkeypox global health emergency

Rediff.com23 Jul 2022

More than 16,000 cases have now been reported from 75 countries and there had been five deaths so far as a result of the outbreak.

CCI orders probe into WhatsApp's new privacy policy

CCI orders probe into WhatsApp's new privacy policy

Rediff.com25 Mar 2021

Fair trade regulator Competition Commission of India (CCI) on Wednesday ordered a detailed probe into popular messaging platform WhatsApp's updated privacy policy and terms of service after finding that the 'exploitative and exclusionary conduct' in the garb of the policy update prima facie violated competition norms.

Right to privacy is deeply linked to national security

Right to privacy is deeply linked to national security

Rediff.com26 Oct 2017

Admittedly, EVMs too have a UID number and any convergence of data can make the secret ballot system a party of history, warns Dr Gopal Krishna in the 5th part of his series against Aadhaar.

DCGI approves Covovax for emergency use in 12-17 yrs age group

DCGI approves Covovax for emergency use in 12-17 yrs age group

Rediff.com9 Mar 2022

Confirming the Drugs Controller General Of India (DCGI) approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted: '@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly.'

Aadhaar is based on unscientific thinking, fallible biometric data

Aadhaar is based on unscientific thinking, fallible biometric data

Rediff.com21 Nov 2017

Biometric authentication is based on the unscientific and questionable assumption that there are parts of human body that does not age, wither and decay with the passage of time.

The many battles that Amazon is fighting in India

The many battles that Amazon is fighting in India

Rediff.com8 Jul 2021

Among all the geographies where Amazon is fighting regulators, India is the only place where its lines are also tangled in a major corporate battle, this one with India's largest company by market capitalisation over the acquisition of Mumbai-based Future Group's retail chain, the country's second largest. No other corporate entity in any country offers a challenge to Amazon's hegemony in a way Reliance Industries does - and the final hearing of an arbitration case filed at the Singapore International Arbitration Centre between the two may decide at least some of these issues. This legal battle between one of the world's most powerful corporations and one of India's most powerful conglomerates could be complicated by a host of other developments.

COVID-19: Mistakes World Must Avoid

COVID-19: Mistakes World Must Avoid

Rediff.com14 Jan 2022

If the pandemic persists, at least a portion of the blame should go to greed and nationalism that got in the way of the world acting together, notes Prosenjit Datta.

How safe is it to play Pokemon in India?

How safe is it to play Pokemon in India?

Rediff.com25 Jul 2016

The user cannot expect his or her privacy to be secured.

Protect the Right to Privacy as a Fundamental Right!

Protect the Right to Privacy as a Fundamental Right!

Rediff.com7 Aug 2015

'The government's proposal to store citizens' data including Aadhaar data under its Digital India initiative on cloud is violative of the citizens' human rights because the cloud is admittedly beyond India's jurisdiction.'

Covaxin gets nod for use in children above 12 years with riders

Covaxin gets nod for use in children above 12 years with riders

Rediff.com25 Dec 2021

The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

'The State must be more tolerant of dissent than it is now'

'The State must be more tolerant of dissent than it is now'

Rediff.com2 Jun 2023

'Nearly 13,000 individuals have been charged for sedition since 2010.' 'If the Supreme Court stay ever gets vacated, arrests will follow immediately.'

Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Rediff.com21 Sep 2021

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller General of India (DCGI), Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said

WHO rejects SII's proposal to extend Covishield's shelf life

WHO rejects SII's proposal to extend Covishield's shelf life

Rediff.com8 Apr 2021

The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

Over Rs 20,000 crore lying unclaimed with LIC

Over Rs 20,000 crore lying unclaimed with LIC

Rediff.com15 Feb 2022

The amount of money lying unclaimed with the Life Insurance Corporation of India dwarfs the budgets of many ministries. There was Rs 21,539.5 crore which lay unclaimed with India's largest insurance company, according to details in the initial public offer (IPO) document it filed over the weekend. The regulatory documentation is ahead of LIC selling shares to the public through the stock exchange for the first time this financial year. This will be India's largest ever public listing.

'India among top countries in illegal wildlife trade'

'India among top countries in illegal wildlife trade'

Rediff.com14 Jun 2022

'With just 2.4 per cent of global landmass, India houses six to eight per cent of planetary biodiversity and hence is a prime target of wildlife criminals.'

Right to privacy: SC asks searching questions

Right to privacy: SC asks searching questions

Rediff.com20 Jul 2017

The top court gave the examples of personal information like thumb impression people voluntarily gave for using mobile phones.

Things Are Looking Up At Box Office, But...

Things Are Looking Up At Box Office, But...

Rediff.com19 Jun 2023

'In terms of ticket sales, Hindi is at 50-60 per cent while the South markets are at 80-90 per cent of pre-pandemic levels.' The patchy performance of Hindi, the largest segment of the business is the nub of what is bothering Indian cinema.

Covid vaccines for children likely by Sept: AIIMS chief

Covid vaccines for children likely by Sept: AIIMS chief

Rediff.com24 Jul 2021

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Trade margins capped at 70% for oximeters, BP meters, other medical devices

Rediff.com14 Jul 2021

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

'India is a great place to do business, come back. Jai Hind'

'India is a great place to do business, come back. Jai Hind'

Rediff.com13 Apr 2018

Businessman P C Mustafa wants Indian Americans to return home, Cognizant CEO Francisco D'Souza outlines how Indian tech companies could grow, Gaurav Dalmia has some investment recommendations while Subramanian Swamy warns that India is flirting with a debt trap.

'We need to know what they mean by clinical trial mode'

'We need to know what they mean by clinical trial mode'

Rediff.com8 Jan 2021

'Ideally, the efficacy data of all the trials should be there in the public domain, and as soon as possible.' 'It is difficult to understand the reason behind the authorisation.'

'Policybazaar IPO minted 70 millionaires, 350 crorepatis'

'Policybazaar IPO minted 70 millionaires, 350 crorepatis'

Rediff.com30 Nov 2021

'My father was asking me what an IPO is. He has no clue and he has never been an investor.' 'My mother, who was the one to ring the bell, has been an investor in Policybazaar for the past 6-7 years and I would say she has made good returns.'

Do you have online insurance fraud queries?

Do you have online insurance fraud queries?

Rediff.com13 Sep 2022

If you have questions related to online insurance frauds, then Piyush Ranjan, chief technology officer, Coverfox Insurance, will answer your queries.

Covid: Insurance claims at 192,863 worth over Rs 3,000 cr

Covid: Insurance claims at 192,863 worth over Rs 3,000 cr

Rediff.com16 Sep 2020

As many as 121,739 claims settled by insurers so far, amounting to Rs 1,165.81 crore.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

India's COVID-19 figures worrying: WHO chief scientist

India's COVID-19 figures worrying: WHO chief scientist

Rediff.com11 May 2021

Soumya Swaminathan called on governments to boost exercises on reporting actual numbers.

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Bio E gets nod for kids' phase 2, 3 Covid vax trial

Rediff.com3 Sep 2021

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology (DBT) said on Friday.

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

Right to privacy can't be absolute: SC on Aadhaar

Right to privacy can't be absolute: SC on Aadhaar

Rediff.com19 Jul 2017

The state may have some power to put reasonable restriction, says the apex court.

HC seeks Centre's reply on plea challenging new digital media rules

HC seeks Centre's reply on plea challenging new digital media rules

Rediff.com9 Mar 2021

The Delhi high court on Tuesday sought the Centre's response on a plea challenging the new Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021, which seeks to regulate digital news media.

Millions of Covid vaccine doses are set to expire in India

Millions of Covid vaccine doses are set to expire in India

Rediff.com20 Jun 2022

Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy these vaccines if nothing works out, Sohini Das reports.

Germany, France, Italy suspend use of AstraZeneca vaccine

Germany, France, Italy suspend use of AstraZeneca vaccine

Rediff.com15 Mar 2021

The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.